HGHRX
Price
$33.64
Change
+$0.51 (+1.54%)
Updated
Aug 15 closing price
Net Assets
754.96M
JNGLX
Price
$68.49
Change
+$0.92 (+1.36%)
Updated
Aug 15 closing price
Net Assets
4.28B
Interact to see
Advertisement

HGHRX vs JNGLX

Header iconHGHRX vs JNGLX Comparison
Open Charts HGHRX vs JNGLXBanner chart's image
Hartford Healthcare R3
Price$33.64
Change+$0.51 (+1.54%)
VolumeN/A
Net Assets754.96M
Janus Henderson Global Life Sciences D
Price$68.49
Change+$0.92 (+1.36%)
VolumeN/A
Net Assets4.28B
HGHRX vs JNGLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HGHRX vs. JNGLX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.29B vs. HGHRX (755M). JNGLX pays higher dividends than HGHRX: JNGLX (0.36) vs HGHRX (0.00). HGHRX was incepted earlier than JNGLX: HGHRX (19 years) vs JNGLX (27 years). HGHRX (1.63) is less costly to investors than JNGLX (0.80). HGHRX is a more actively managed with annual turnover of: 40.00 vs. JNGLX (35.00). HGHRX has a lower initial minimum investment than JNGLX: HGHRX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -14.24 vs. HGHRX (-20.13). JNGLX return over 5 years is better than : 5.06 vs. HGHRX (-20.74).
HGHRXJNGLXHGHRX / JNGLX
Total Expense Ratio1.630.80204%
Annual Report Gross Expense Ratio1.630.80204%
Fund Existence19 years27 years-
Gain YTD-5.0790.884-575%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets755M4.29B18%
Annual Yield % from dividends0.000.36-
Returns for 1 year-20.13-14.24141%
Returns for 3 years-8.696.21-140%
Returns for 5 years-20.745.06-410%
Returns for 10 years-21.7712.18-179%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYCN2.360.03
+1.07%
Cyclerion Therapeutics
ANAB20.140.17
+0.85%
AnaptysBio
IMVT15.220.02
+0.13%
Immunovant
PFG77.64-0.45
-0.58%
Principal Financial Group
TUSK2.24-0.05
-2.18%
Mammoth Energy Services